Air pollution is linked to increased emergency department visits for headache and migraine patients frequently cite chemicals or odors as headache triggers, but the association between air pollutants and headache is not well understood. We previously reported that chronic environmental irritant exposure sensitizes the trigeminovascular system response to nasal administration of environmental irritants. Here, we examine whether chronic environmental irritant exposure induces migraine behavioral phenotypes. Male rats were exposed to acrolein, a transient receptor potential channel ankyrin-1 (TRPA1) agonist, or room air by inhalation for 4 days before meningeal blood flow measurements, periorbital cutaneous sensory testing, or other behavioral testing. Touch-induced c-Fos expression in trigeminal nucleus caudalis was compared in animals exposed to room air or acrolein. Spontaneous behavior and olfactory discrimination was examined in open-field testing. Acrolein inhalation exposure produced long-lasting potentiation of blood flow responses to a subsequent TRPA1 agonist and sensitized cutaneous responses to mechanical stimulation. C-Fos expression in response to touch was increased in trigeminal nucleus caudalis in animals exposed to acrolein compared with room air. Spontaneous activity in an open-field and scent preference behavior was different in acrolein-exposed compared with room air-exposed animals. Sumatriptan, an acute migraine treatment blocked acute blood flow changes in response to TRPA1 or transient receptor potential vanilloid receptor-1 agonists. Pretreatment with valproic acid, a prophylactic migraine treatment, attenuated the enhanced blood flow responses observed after acrolein inhalation exposures. Environmental irritant exposure yields an animal model of chronic migraine in which to study mechanisms for enhanced headache susceptibility after chemical exposure.
Introduction
Despite extensive research, migraine remains the most undertreated neurological disorder. In particular, chronic (or transformed) migraine (defined as 15 or more days of headache per month, International Classification of Headache-3) is more debilitating and refractory to treatment compared with episodic migraine. The mechanisms underlying the progression from episodic to chronic migraine are not understood. Some factors increase the risk of migraine progression, including increases in the number of baseline attacks. In addition, migraines may be triggered by environmental stimuli such as air pollutants and odors. 20 Repeated or continuous exposure to chemicals or poor air quality has been linked to the acquired disorder, multiple chemical sensitivity (MCS), wherein patient complaints include headache. 11 Furthermore, MCS is associated with increased sensitivity to a variety of chemicals, a number of which are transient receptor potential channel ankyrin-1 (TRPA1) agonists.
Transient receptor potential channel ankyrin-1 is an excitatory ion channel expressed in trigeminal sensory neurons and has been linked to migraine. 3, 38 We have hypothesized that air pollution-induced headache is induced by stimulation of TRPA1 receptors in nasal epithelium and subsequent activation of the trigeminovascular system, believed to be important in headache. Activation of the trigeminovascular system can be assayed with laser Doppler flowmetry and has been shown to be predictive of clinical efficacy of headache therapeutics. 1, 15, 16, 28, 33 We reported that acute nasal administration of environmental irritants increases meningeal blood flow in a TRPA1-and calcitonin gene-related peptide receptor-dependent manner. 25 In addition, preexposure to environmental irritants such as acrolein may activate and sensitize TRPA1 receptors in the trigeminovascular pathway and thus predispose subjects to headache. We chose to examine this possibility using acrolein because it is prevalent in both indoor and outdoor air pollution and its health effects are well documented. 9, 14, 22, 23 In this regard, we have shown that repeated (chronic) inhalation of subacute doses of acrolein potentiates blood flow responses to subsequent acute irritant exposure, 27 with no other harmful effects. This suggests that TRPA1 receptors may play a pivotal role in the conversion of episodic to chronic migraine after environmental irritant exposures. From these observations, we predict that a chronic episodic inhalation paradigm, in addition to producing longlasting trigeminovascular sensitization, will induce additional phenotypes consistent with chronic migraine. Sufferers of chronic migraine report a constellation of symptoms including cutaneous allodynia, sensitivity to smell, light, and sound, and Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. 
Methods

Animals
All animal procedures were approved by the Institutional Animal Care and Use Committee at the Indiana University School of Medicine and followed the ethical guidelines of International Association for the Study of Pain. 60 Experiments were performed on 130 adult male (170-250 g) Sprague-Dawley rats (Harlan Bioproducts, Indianapolis, IN). Rats were housed in pairs in solid bottom cages with hardwood chip bedding with a standard 12-hour light and dark cycle with free access to food and water. Animals were randomly assigned to experimental groups and weighed daily during treatment. No adverse effects of treatment were observed.
Inhalation exposure
Rats were exposed to acrolein by mixing acrolein gas (Air Liquide, Plumsteadville, PA) and room air to obtain the desired concentration as described previously. 5 The acrolein dosage (0.3 ppm) was chosen because it produced minimal or no detectable harmful effects in previous studies. 9, 14, 27, 31 In addition, it is equivalent to the limit for short-term exposure recommended by the National Institute of Occupational Safety and Health. Separate inhalation chambers (5.5 L total volume; Braintree Scientific, Inc, Braintree, MA) and tubing were used for acrolein and control groups to avoid cross contamination. The flow rate was maintained at 1.5 L/min, and temperature and humidity were monitored in the chamber. Based on previous studies, 9, 14, 27, 31 rat pairs were exposed to acrolein 0.30 6 0.03 ppm (n 5 70) 4 hours per day for 4 days while control animals were exposed to room air with the same paradigm. Cumulative acrolein exposure for each animal was determined with monitoring badges placed in the chamber (Advanced Chemical Sensors Inc, Boca Raton, FL). Laser Doppler flowmetry was conducted in separate groups of animals at either 1, 4, or 7 days after the last inhalation exposure as described below.
Laser Doppler flowmetry
Laser Doppler flowmetry was performed as previously described 25 between 10:00 and 15:00. Rats were anesthetized with ketamine/ xylazine (80 and 10 mg/kg body weight, respectively), followed by additional doses of ketamine/xylazine (40 and 5 mg/kg body weight) as needed. Body temperature was maintained at 37˚C with a homeothermic blanket. For the measurement of meningeal blood flow, the skull was fixed in a stereotaxic frame and a cranial window prepared 25 with the dura left intact. Dural blood flow was measured with a laser Doppler flowmeter (TSI, Shoreview, MN). A needle-type probe was placed over a large branch of the middle meningeal artery, distant from visible cortical blood vessels, and the cranial window kept moist with synthetic interstitial solution (SIF) consisting of 135 mM NaCl, 5 mM KCl, 5 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, and 10 mM D-glucose (pH 7.3). Blood flow was sampled at 1 Hz with a Digidata 1320 interface using Axoscope software (Axon Instruments, Sunnyvale, CA).
Blood flow drug administration
To stimulate the nasal mucosa, 25 mL of test compound or vehicle solution was applied over a 30-second period at a site 2 mm into the right nostril using a Pipetman pipette. 21, 25 Solutions of TRPA1 agonists, mustard oil, and acrolein (Sigma, St. Louis, MO) were prepared fresh daily by diluting in SIF to the desired concentrations. Stock solutions of the transient receptor potential vanilloid receptor-1 (TRPV1) agonist and capsaicin (10 mM; Sigma) were dissolved in ethanol and stored at 220˚C and then diluted to the desired concentration with SIF before use. Submaximal concentrations of agonist were used for sensitization studies 27 (ie, 10 mM of mustard oil), whereas higher doses (30 mM of mustard oil) were used for sumatriptan and valproic acid testing. A 30-minute stabilization period preceded all test drug applications to ensure steady basal blood flow measurements. Each animal in blood flow experiments was given nasal saline as a vehicle control 15 minutes before administering the TRP agonist. Saline produced less than 2% change in blood flow on average consistent with our previous published results 25, 26 (data not shown). For acute drug studies, rats received a single injection of saline or sumatriptan (1 mg/kg, i.p., 37 ) (Santa Cruz Biotechnology, Dallas, TX) 2 hours before blood flow drug administration. For chronic drug experiments, rats received daily injections of vehicle (saline; 200 mL injection volume, i.p.) or valproic acid (200 mg/kg, i.p, 37 [Sigma]) diluted in vehicle for 4 days before inhalation chamber exposure followed by daily injections 30 minutes before chamber exposure (8 total injections).
Tactile sensory testing
Rats were tested during the daylight portion of their circadian cycle (09:00-12:00 hours) and followed the protocol described by Oshinsky and Gomonchareonsiri. 36 Rats were placed in a plastic tube restraint (inner diameter 8 cm and length 20 cm), which was used to prevent the animals from walking away from the sensory testing. Rats were acclimated to the testing apparatus through training periods before testing and entered the restraint tube uncoaxed. The onset of cutaneous sensitivity was assessed at 4 time points relative to the inhalation paradigm; 1 day before inhalation chamber (Pre, as labeled on figures), 30 minutes after the first exposure (1) or after the fourth exposure (4), and 24 hours later (Post). The duration of cutaneous sensitivity was assessed by von Frey testing at 1, 4, or 7 days after inhalation exposure. Forceresponse thresholds were determined by applying von Frey monofilaments (North Coast Medical, Inc, Morgan Hill, CA) to the midline periorbital region of the rat. The von Frey stimuli were presented in a sequential ascending or descending order, as necessary to determine the threshold response, as previously described. 10, 19 A positive response for the von Frey test was defined as when the rat withdrew its head away from the stimulus or stroked its face with the forepaw at least 2 of 3 trials. The testing was recorded on video and scored twice: once by the experimenter and again by a blinded observer who scored the video playback. The 2 scores were averaged, and the results were presented as the threshold in grams 6SEM, which elicited a response.
Touch-induced c-Fos expression experiments followed the procedures of Boyer et al. 5 with modifications. Twenty-four hours after the last acrolein or room air chamber exposure, rats were stimulated with an 8-gm von Frey filament on the midline periorbital region (1 Hz, for 1 minute) while restrained by the experimenter. The rats were perfused transcardially with 4% paraformaldehyde and processed for immunocytochemistry 90 minutes later. To assess whether restraining the animals during the von Frey filament touch experiments might have independent effects on c-Fos expression, a group of acroleinexposed restrained-only animals was also included.
Open-field testing
Open-field and scent preference testing was conducted as previously described. 7 Rats subjected to either acrolein or room air were tested in an open field 24 hours after the last exposure. Rats were placed in the center of a 90 3 90 cm opaque box, and behavior was video recorded for 5 minutes and later analyzed by an experimenter, who was blind to the treatments, using ANYmaze software (version 4.75; Stoelting, Wood Dale, IL), an automated video tracking system for behavioral experiments. Rats were placed back into their home cages for 30 minutes before additional testing. Scent preference was tested as above with one corner of the box-containing Millipore water (neutral scent) and the opposite corner containing either a pleasant (Kroger brand Imitation Vanilla extract; Vanilla, Kroger Cincinnati, OH) or unpleasant (fox urine; Maine Outdoor Solutions, Herman, ME) scent. Specifically, the scents were placed on a cotton swab and then taped to the inside of a petri dish (100 3 15 mm) and allowed to dissipate under a fume hood for 2 hours before testing. They were then covered and placed outside the testing room. Before each exposure, the dish was brought in to the room, taped to the bottom of the apparatus, and uncovered. The animals were placed into the center of the apparatus and allowed for 5 minutes to explore the arena and scents. The animals were then placed back into their home cage and allowed for 4 to 5 minutes while the apparatus was cleaned with Coverage Plus (Fisher, Hampton, NH), and the scent removed and placed outside the room. The new scent was brought in and taped to the apparatus, and again, the animals were placed in the center and allowed for 5 minutes to explore. The scents were randomized between subject, with half getting vanilla scent first and half getting predator scent first. Behavior was videotaped and analyzed as above.
Immunocytochemistry
To determine whether irritant exposure, restraint, or periorbital stimulation-induced c-Fos expression in spinal trigeminal nucleus caudalis (TNC) neurons, immunocytochemistry was performed as described previously. 19 After overnight fixation, the tissue was rinsed in phosphate-buffered saline (PBS) and then cryoprotected in 10% sucrose for 2 hours followed by 20% sucrose in PBS overnight at 4˚C. Frozen coronal sections (40 mm) of the brainstem and spinal cord were obtained serially through the medulla to the third cervical segment and collected free-floating in PBS. The obex was used as the most rostral point and was designated 0.0 mm. The first 6 serial sections from regions at 1.5, 3.0, 4.5, and 6.0 mm caudal to the obex were processed and examined in each animal. Sections were blocked in 4% normal goat serum and 0.025% Triton-X100 in PBS for 1 hour and incubated with the primary antibody (c-Fos; Santa Cruz [#sc-52]; 1:2000) diluted in blocking solution overnight at 4˚C. Subsequently, sections were rinsed in PBS, incubated with the secondary antibody (goat antirabbit IgG conjugated to horseradish peroxidase; Jackson ImmunoResearch, West Grove, PA; 4 mg/mL) for 1 hour at room temperature and processed for visualization using DAB. Cells were considered positive for c-Fos immunoreactivity (cFos-IR) if the nucleus was densely stained. No reactivity was observed in control sections in which primary antibody was omitted.
Data collection and statistics
For blood flow experiments, data were collected at 1 Hz. Basal blood flow was determined as the mean flow rate measured during a 4-minute period before drug application, and the effects of test compounds were calculated by comparing the peak response after drug or saline administration to the basal blood flow. Changes in blood flow were calculated relative to the basal blood flow for each animal, averaged within treatment groups, and expressed as percent changes.
Comparison of blood flow changes was performed using a 2-tailed Student's t test with Welch's correction for populations, which have unequal SDs. For graphical representation, the average percent changes of acrolein-exposed animals were normalized to the average percent changes of room air-exposed animals (Fig. 1) . For touch-induced c-Fos experiments, c-Fos-IR cells in the superficial laminae (ie, I and II) of the TNC from 6 brain sections were manually counted in a blinded fashion at each level with a 310 objective (3100 overall magnification). Anatomical boundaries were determined by coordinates established by the Paxinos and Watson 39 rat brain atlas. Left and right side cell counts from each section/level were combined per animal and compared between treatment groups. Two-way analysis of variance (ANOVA) and Sidak's post hoc tests were performed on periorbital allodynia and c-Fos-IR cell counts. Comparison of open-field behavior and scent preference was performed using a 2-tailed Student's t test. Data presentation and statistical analyses were performed using GraphPad Prism software (GraphPad, CA). Averaged data values are presented as mean 6 SEM. The significance level for all tests was set at P , 0.05. Blood flow changes in the middle meningeal artery after nasal administration of mustard oil (MO) in male rats exposed to room air or acrolein. Representative traces of middle meningeal blood flow changes in response to nasally applied MO after 1, 4, and 7 days after exposure to 4 3 4 acrolein or room air. Arrows indicate nasal administration of MO. Compared with room air-exposed animals, blood flow changes to nasal MO (10 mM) administration were significantly increased in acrolein-exposed male rats at 1, 4, and 7 days after acrolein inhalation chamber. Values are normalized to average blood flow changes in room air-exposed animals at the same time point (depicted as a dotted line on graph). *P , 0.05 compared with changes in room air-exposed animals at the same time point. N 5 5 to 10 animals per group.
Results
Acrolein inhalation produces long-lasting sensitization of meningeal blood flow
We previously reported that repeated subacute acrolein exposure significantly increased subsequent blood flow responses to TRP agonists 24 hours later. 27 To determine the duration of the sensitization, we conducted blood flow experiments at 1, 4, or 7 days after acrolein or room air inhalation in separate groups of animals. We observed sensitization of the blood flow response at all time points relative to room air-exposed animals (Fig. 1) . ] , P , 0.05) after the last exposure. As depicted in Figure 1 , when normalized to changes in blood flow responses observed in room air-exposed rats, the acrolein-exposed animals exhibited 315%, 238%, and 163% higher responses at 1, 4, and 7 days after inhalation, respectively. Despite migraine being more prevalent in women than in men, 51 we observed a similar sensitization in female rats exposed to acrolein 1 day after the last exposure (312%, data not shown).
Acrolein exposure induces long-lasting periorbital allodynia and potentiates touch-induced c-Fos expression in trigeminal nucleus caudalis
To assess whether the acrolein inhalation model produces migraine pain phenotypes, we assessed periorbital cutaneous allodynia before and after the inhalation exposures and before the blood flow experiments in rats ( Fig. 2A) . Two-way ANOVA indicated significant effects for both time F(3,42) 5 7.233 and treatment F(1,14) 5 8.450. Before inhalation exposure, there were no differences in withdrawal responses to von Frey stimulation applied to the periorbital region. Similarly, no differences in withdrawal responses to cutaneous stimulation between acrolein and room air-exposed animals followed one 4-hour exposure period (8.5 6 0.5 g vs 9.1 6 0.5 g, P 5 0.894). By contrast, animals exposed to repeated daily acrolein inhalation developed periorbital allodynia, which remained 1 day later. After the 4 3 4 acrolein exposures, von Frey withdrawal thresholds were significantly reduced compared with room air only (6.6 6 0.6 g vs 8.9 6 0.4 g, P , 0.05, respectively). Twenty-four hours later, the withdrawal threshold response remained significantly reduced in the acrolein-exposed animals compared with room air-control animals (5.4 6 0.7 g vs 9.1 6 0.3 g and P , 0.05, respectively). To determine the duration of periorbital allodynia after 4 3 4 acrolein exposures, periorbital allodynia was assessed at 1, 4, and 7 days after inhalation of room air or acrolein in separate groups of rats (Fig. 2B) . Two-way ANOVA indicated significant effects for both time F(3, (Fig. 2B) followed a similar pattern of duration, that is, the sensitization peaks 1 day after inhalation chamber and decreases over time.
The 4 3 4 acrolein exposure model induces periorbital allodynia ( Fig. 2A and B) , a frequent complaint of chronic migraine patients, which is believed to be a manifestation of central sensitization. We thus sought to determine whether changes are occurring centrally in the TNC, using c-Fos expression to monitor neuronal activation. Consequently, we compared c-Fos expression in acrolein-and room air-exposed animals after normal nonnoxious mechanical stimulation (Fig. 3) . We observed very low levels of c-Fos-IR expression in each of the brainstem and spinal cord sections of room air-exposed touch animals, consistent with the results from the withdrawal threshold studies (Fig. 2) indicating that an 8-g von Frey filament stimulation is innocuous (Fig. 3A) . Likewise, acrolein-exposed animals subjected to only restraint had similarly sparse c-Fos-IR expression (Fig. 3B) . However, 2-way ANOVA indicated significant effects for both level F(3,63) 5 9.37 and treatment Figure 2 . Development and maintenance of periorbital allodynia after repeated acrolein exposure. (A) Periorbital cutaneous responses to von Frey filament stimulation after repeated acrolein vapor or room air exposure. Cutaneous mechanical sensitivity was assessed before (Pre), 30 minutes after exposure on days 1 and 4, and 24 hours (Post) after the last chamber exposure. Von Frey thresholds were significantly reduced in acrolein-exposed animals after the fourth exposure and remained lower at 24 hours after the last exposure. *P , 0.05 compared with acrolein-exposed animals. (B) Maintenance of periorbital allodynia after repeated acrolein exposure. Periorbital cutaneous responses were assessed either 1, 4, or 7 days after acrolein or room air exposure. Von Frey thresholds were significantly reduced in acrolein-exposed animals 1 day and 4 days but not 7 days after acrolein exposure relative to room air-exposed animals. *P , 0.05 compared with acrolein-exposed animals. 
Acrolein exposure modifies open-field and scent preference behaviors
Spontaneous behavioral changes are important in validating chronic migraine models 32, 43, 44, 52 including reduced activity levels. 32 To examine general activity levels, rats subjected to either the acrolein or room air 4 3 4 protocol were tested in an open field 24 hours after the last exposure (Fig. 4) . Testing was conducted over 5 minutes and analyzed by video recording as previously described. 7 Representative occupancy maps (warmer color 5 higher occupancy) indicate where animals spent their time. Time spent in corners was significantly increased in acrolein-exposed animals compared with room air-exposed animals (189 6 8 vs 159 6 5 seconds, P , 0.05; Fig. 4A and B) . Interestingly, time in periphery, inner time, distance traveled, and mean speed did not significantly differ between the groups (data not shown), suggesting that this phenotype did not fit a pattern reflective of anxiety.
Despite the fact that odors and chemicals are known migraine triggers 47 and osmophobia is a complaint in 25% to 40% of chronic migraineurs, 4, 24, 42, 49 this feature has not been explored in a rodent model of migraine. Osmophobia is an aversion to either pleasant or unpleasant scents. To determine whether acrolein-or room air-exposed animals differ in their behavior toward scents, open-field testing was performed in which one corner contained water (neutral odor) and the opposite corner contained either a pleasant scent (vanilla) or an unpleasant scent (predator). Rats preexposed to acrolein vs room air spent significantly more time in nonscent corners during discrimination testing for the pleasant scent (119 6 13 vs 66 6 13 seconds, P , 0.05, respectively) ( Fig. 4C and D) . Furthermore, rats preexposed to acrolein vs room air also spent significantly more time in nonscent corners during testing for unpleasant scent discrimination (93 6 15 vs 61 6 6 seconds, P , 0.05) (Fig. 4E and F) . Overall, the behavior of acrolein-exposed animals differs from room air-exposed animals in both open-field and scent preference testing. .0 mm caudal to the obex were processed and examined in each animal. Periorbital von Frey filament stimulation significantly increased c-Fos expression in acrolein-exposed touch animals (n 5 7) compared with room air-exposed touch animals (n 5 8) and with acrolein-exposed animals subjected only to restraint (n 5 8). Note that no differences were observed between the acrolein-exposed restraint only and the room air-touch animals. *P , 0.05 compared with room air-touch animals, #P , 0.05 compared with acrolein-exposed restraint-only animals at the same level. Scale bar 5 200 mm.
Sumatriptan blocks acute meningeal blood flow response to nasal administration of transient receptor potential agonists
Migraine models which are predictive of clinical outcome are essential to allow for comparison of currently efficacious treatments to novel potential therapeutics. Therefore, we examined the effects of sumatriptan, a drug effective in acute migraine but not generally efficacious for chronic migraine on meningeal blood flow responses to acute nasal administration of TRP agonists (Fig. 5) . A single dose of sumatriptan (1 mg/kg, i.p.) administrated 2 hours before nasal application of agonist significantly attenuated the blood flow response to acrolein (Fig. 5A ) compared with control animals receiving a saline injection (6 6 1% [n 5 5] vs 78 6 11% [n 5 6], P , 0.05). Sumatriptan also attenuated meningeal blood flow induced by nasally administered capsaicin (Fig. 5B) . Blood flow responses were significantly reduced in animals injected with sumatriptan compared with saline controls (20 6 6% [n 5 5] vs 131 6 23% [n 5 7] , P , 0.05).
Pretreatment with valproic acid blocks acrolein-induced trigeminovascular sensitization
To assess the efficacy of a prophylactic migraine drug treatment in the sensitization phenomenon, we asked whether concomitant treatment with a chronic migraine drug during acrolein conditioning would block the subsequent potentiation. Valproic acid is (A and B) , the time spent in corners is increased in acrolein-exposed animals compared with room air controls. Representative occupancy maps for individual animals exposed to room air (B, left) or acrolein (B, right) are displayed where warmer colors represent higher occupancy. Scent preferences with water and vanilla (C and D) or water and predator scent (E and F) were determined in separate tests. W, V, or P indicate placement of water, vanilla, or predator scent in the corners of the open-field\ chamber. Summarized data indicates that time spent in nonscent corners is increased in response to pleasant (C) or unpleasant (E) scents in acrolein-exposed animals compared with room air controls. The corner is defined as the single most peripheral quadrant. *P , 0.05 compared with room air animals. The number of animals per group is indicated. sometimes used off-label as a prophylactic treatment for chronic migraine 50 and is efficacious in preclinical migraine models, 30 although its mode of action is not well understood. 45 We injected valproic acid (200 mg/kg, i.p.) into animals once per day for 4 days before and daily 30 minutes before placing each animal in the inhalation chamber (8 injections total). Control animals received saline injections. Blood flow responses were measured approximately 24 hours after the last inhalation period and in the absence of vehicle or valproic acid injections. Similar to our previous report, 27 conditioning acrolein exposure potentiated the blood flow responses to 10 mM mustard oil relative to room air exposure (34 6 6% [n 5 6] vs 16 6 2% [n 5 6], P , 0.05) in vehicle-injected animals (Fig. 6) . Trigeminovascular responses were significantly blunted in those acrolein-exposed animals injected with valproic acid compared with acrolein-exposed animals injected with vehicle (9 6 2% [n 5 6] vs 34 6 6% [n 5 6], P , 0.05). In addition, no differences were observed between room air-exposed animals pretreated with valproic acid compared with those receiving only saline (11 6 2% [n 5 7] vs 16 6 2% [n 5 6]).
Discussion
Environmental factors including odors and air pollution are some of the most widely reported triggers of migraine. 20 Although not extensively studied, several reports have demonstrated strong links between air borne chemicals and headache. 35, 54, 55, 58 Recently, it has been suggested that TRPA1 agonists are critically involved in air pollution-induced human headache. TRPA1 agonists, including acrolein and formaldehyde, are environmental irritants found in indoor and outdoor pollution. Also of particular relevance is the "headache tree," Umbelluria californica whose vapors can induce severe headaches in susceptible individuals. 2, 34 The active component of these vapors, umbellulone, is an identified TRPA1 agonist, 59 capable of activating the trigeminovascular system. 34 Headache precipitated by air pollutants is a symptom of MCS, an acquired disorder linked to inhaled chemicals. 12 Other MCS symptoms include skin and respiratory ailments reflecting an increased sensitivity to subsequent exposures to a variety of chemicals. It is, however, not clear how inhaled irritants induce headache and other symptoms. Because of the similarities of trigeminovascular responses in our rat model to MCS phenotypes and because air pollution as a health factor is increasing worldwide, we wanted to determine whether preexposure to inhaled irritants sensitizes the trigeminovascular system. Using the 4 3 4 inhalation model to expose animals to room air vs subacute acrolein (0.3 ppm), we confirmed that acrolein-exposed animals exhibit sensitized trigeminovascular responses to subsequent nasal TRP agonist challenge, and we also demonstrate that the sensitization is long lasting, that is, still present 7 days after the last exposure to a nontoxic level of acrolein.
As one of the most important risk factors for chronic migraine is frequency of headache episodes at baseline, it has been proposed that "an animal model of chronic migraine should mimic recurrent activation of the trigeminal system." 36 It is not clear how the trigeminovascular system is activated in migraine but sensitization of peripheral neural elements may be involved. Therefore, most models include repeated administration of In saline-injected animals, the blood flow response to nasal mustard oil (10 mM) was significantly increased in acrolein-exposed animals compared with room air exposed. No difference in blood flow response was observed between acrolein or room air-exposed animals injected with valproic acid, but a significant difference in blood flow response to nasal mustard oil administration was observed between saline-and valproic acid-injected animals exposed to acrolein. (*P , 0.05). Values are mean 6 SEM. The number of animals per group is indicated. agents to peripheral nociceptors in the meninges, 32, 36, 56, 57 or systemically, that is, nitroglycerin. 40 Our inhalation model differs in that we repeatedly activate the trigeminovascular system through stimulation of peripheral trigeminal afferents in the nasal mucosa. This model induces some of the expected phenotypes but with the distinct advantage of using a known exteroceptive trigger rather than an invasive method.
In addition to headache, patients with migraine uniquely exhibit other symptoms including cutaneous allodynia, photophobia, phonophobia, and osmophobia, which tend to be more prevalent and severe in chronic migraine sufferers. Therefore, it is important that chronic migraine models exhibit some of these traits. Facial cutaneous allodynia is common in 60% to 80% of migraineurs with the prevalence and severity higher in chronic migraine. 8 After acrolein exposure, we tested for periorbital allodynia and c-Fos activation in the TNC. Periorbital allodynia was induced by repetitive acrolein inhalation and persisted 24 hours after the last exposure. This mimics the observations of Oshinsky and Gomonchareonsiri 36 who first reported periorbital allodynia after repeated administrations of inflammatory mediators to the dura. Others have also observed long-lasting allodynia after repeated inflammatory mediators 5, 18, 43, 53 or TRPA1 agonists 17 administered to the dura. Similar long-term facial allodynia has been described 40 after repeated systemic injections of nitroglycerin a known migraine trigger. C-Fos expression in response to light touch was also enhanced in the TNC by repetitive acrolein inhalation, similar to results obtained in other animal models of chronic migraine. 5 Osmophobia has been cited as a unique trigger and perhaps diagnostic symptom of migraine. 42, 46, 48 Approximately 40% of migraineurs report osmophobia as a symptom. 4, 49 As aversion to scents has not been previously examined in animal models of migraine, we compared the behavior of acrolein-and room air-exposed animals to pleasant and unpleasant scents in an open-field test. Under testing with either pleasant or unpleasant scents, the acrolein-exposed animals spent more time in corners without any scent. This is an intriguing finding as osmophobia is common in humans with migraines. Additional studies are warranted, however, to determine whether these behaviors are due to general olfactory disturbances, neophobia, or pain.
Spontaneous behavior changes in migraine models are increasingly important, 32, 52 and several laboratories have observed changes in grooming patterns, exploratory behavior, and general activity levels. These altered spontaneous behaviors may be more relevant than evoked behaviors as migraineurs similarly display reduced physical activity and avoidance behaviors (ICHD-3). Consequently, we explored such behaviors through open-field testing. Neither total distance traveled nor average speed was affected by repetitive acrolein exposure. This differs from some studies, which used other induction methods. 32, 53 Unexpectedly, the acrolein-exposed rats spent more time in corners of the openfield test. This is not merely more anxiety because our laboratories have extensively used open field to test anxiety behaviors and rats with high anxiety (eg, poststressful stimuli) spend more time displaying thigmotaxis (ie, near walls of arena) but do not typically show more time spent in corners (usually only the center time is published, the corner data is unpublished). Collectively, these data may reflect a general avoidance behavior or pain state (eg, migraines) after exposure to the environmental irritant, acrolein.
Another important value of validated migraine models is their potential utility in testing new migraine therapeutics. In this regard, we have begun testing our model with known efficacious drugs (eg, triptans) to initially assess this dimension. In naive animals (ie, the absence of repetitive inhalation exposure), sumatriptan effectively blocks blood flow changes induced by acute nasal administration of TRPA1 or TRPV1 agonists (Fig. 5) . Here, we further report that valproic acid, an antiseizure medicine sometimes used prophylactically for chronic migraine was effective at blocking the trigeminovascular sensitization when administered during conditioning acrolein exposure (Fig. 6 ). These results demonstrate that this novel model of chronic migraine induced by environmental irritant exposure may be useful in testing new therapeutics for chronic migraine, a condition which is difficult to manage with few recognized treatments. Although these studies suggest that chronic acrolein exposure-induced enhanced trigeminovascular system responses, the mechanistic link between TRPA1 activation by acrolein and the observed responses remain undetermined. TRPA1 and TRPV1 are often coexpressed in nociceptive sensory neurons and have been suggested to work in concert to activate in response to TRPA1 agonists. Although activation of these receptors can lead to nociceptor excitation, the depolarization induced can also result in an increase in firing threshold because of sodium channel inactivation. Although in vitro evidence 13 has suggested that acrolein may not directly excite meningeal afferents, the sequelae and interactions between nasal and meningeal afferents in vivo seems to be TRPA1 dependent and pronociceptive. 17 Nonetheless, the specific mechanism by which repetitive activation of TRPA1 induces behavioral sensitization remains a mystery. We have previously observed changes in lipids in the trigeminal ganglion after acrolein exposure. 29 We speculate that acrolein acting on TRPA1 channels may drive changes in lipid levels, which in turn, can activate or sensitize TRP channels. This is supported by lipidomic studies, which have identified novel endogenous lipids that are TRP channel activators/modulators. 6, 41 In summary, our results suggest that inhalation exposure to environmental irritants induces trigeminovascular and central sensitization and reproduces some facets of chronic migraine models. Importantly, our conditioning protocol represents the first model to use a known exteroceptive physiological and environmental trigger of human migraine. Furthermore, this novel model reinforces the hypothesis that TRPA1 receptors have important roles in episodic to chronic transformation in migraine and provides a platform to better understand the progression to chronic migraine and develop novel therapeutics.
